星空体育官方入口网站网址大全-登录入口官网

#ACS患者#

59篇内容 | 1445人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1575006, encodeId=cb2e15e5006ca, content=<a href='/topic/show?id=52ab188e48' target=_blank style='color:#2F92EE;'>#ACS患者#</a>, objectTitle=双联抗血小板药物多立维®在华上市，进一步提升ACS患者用药依从性, objectType=article, longId=727521, objectId=51cae2752113, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=51cae2752113, replyNumber=0, likeNumber=68, createdTime=2022-05-23, rootId=0, userName=neurosurgeon, userId=bf9f16042984, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=51cae2752113, moduleTitle=双联抗血小板药物多立维®在华上市，进一步提升ACS患者用药依从性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=51cae2752113)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1575005, encodeId=e20115e500520, content=<a href='/topic/show?id=52ab188e48' target=_blank style='color:#2F92EE;'>#ACS患者#</a>, objectTitle=CARDIOVASC DIABETOL：糖化白蛋白（GA）对NSTE-ACS患者经皮冠状动脉介入治疗的预后意义, objectType=article, longId=294887, objectId=586429488eba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=586429488eba, replyNumber=0, likeNumber=51, createdTime=2022-01-30, rootId=0, userName=neurosurgeon, userId=bf9f16042984, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=586429488eba, moduleTitle=CARDIOVASC DIABETOL：糖化白蛋白（GA）对NSTE-ACS患者经皮冠状动脉介入治疗的预后意义, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=586429488eba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1575004, encodeId=b18315e500461, content=<a href='/topic/show?id=52ab188e48' target=_blank style='color:#2F92EE;'>#ACS患者#</a>, objectTitle=JACC：采用双重抗血小板治疗的ACS患者或许不需停用氯吡格雷5天后才能进行冠脉搭桥术, objectType=article, longId=208463, objectId=572b208463ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=572b208463ff, replyNumber=0, likeNumber=69, createdTime=2021-03-17, rootId=0, userName=neurosurgeon, userId=bf9f16042984, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=572b208463ff, moduleTitle=JACC：采用双重抗血小板治疗的ACS患者或许不需停用氯吡格雷5天后才能进行冠脉搭桥术, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=572b208463ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1575003, encodeId=02cb15e5003d2, content=<a href='/topic/show?id=52ab188e48' target=_blank style='color:#2F92EE;'>#ACS患者#</a>, objectTitle=EuroIntervention：接受COMBO支架治疗的ACS患者，3个月vs12个月的DAPT结局——REDUCE试验结果, objectType=article, longId=203297, objectId=cfda20329e51, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cfda20329e51, replyNumber=0, likeNumber=85, createdTime=2020-11-14, rootId=0, userName=neurosurgeon, userId=bf9f16042984, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cfda20329e51, moduleTitle=EuroIntervention：接受COMBO支架治疗的ACS患者，3个月vs12个月的DAPT结局——REDUCE试验结果, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=cfda20329e51)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1575002, encodeId=f4bb15e500298, content=<a href='/topic/show?id=52ab188e48' target=_blank style='color:#2F92EE;'>#ACS患者#</a>, objectTitle=专家访谈:生命至上——PCSK9抑制剂值得被更多ACS患者使用, objectType=article, longId=201145, objectId=331b20114592, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=331b20114592, replyNumber=0, likeNumber=63, createdTime=2020-09-26, rootId=0, userName=neurosurgeon, userId=bf9f16042984, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=331b20114592, moduleTitle=专家访谈:生命至上——PCSK9抑制剂值得被更多ACS患者使用, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=331b20114592)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1575001, encodeId=dc7015e500181, content=<a href='/topic/show?id=52ab188e48' target=_blank style='color:#2F92EE;'>#ACS患者#</a>, objectTitle=ESC 2020:ACS患者LDL-C管理：低一些好一些，早一些好一些？！, objectType=article, longId=200806, objectId=e491200806c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e491200806c7, replyNumber=0, likeNumber=71, createdTime=2020-09-19, rootId=0, userName=neurosurgeon, userId=bf9f16042984, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e491200806c7, moduleTitle=ESC 2020:ACS患者LDL-C管理：低一些好一些，早一些好一些？！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e491200806c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1575000, encodeId=e39915e5000fe, content=<a href='/topic/show?id=52ab188e48' target=_blank style='color:#2F92EE;'>#ACS患者#</a>, objectTitle=指南直通车|长期口服抗凝剂NSTE-ACS患者的抗血小板治疗, objectType=article, longId=200095, objectId=248e2000953f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=248e2000953f, replyNumber=0, likeNumber=54, createdTime=2020-09-02, rootId=0, userName=neurosurgeon, userId=bf9f16042984, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=248e2000953f, moduleTitle=指南直通车|长期口服抗凝剂NSTE-ACS患者的抗血小板治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=248e2000953f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574999, encodeId=f89e15e49995d, content=<a href='/topic/show?id=52ab188e48' target=_blank style='color:#2F92EE;'>#ACS患者#</a>, objectTitle=JACC: 吗啡和氯吡格雷不要同时用！增加ACS患者缺血事件风险, objectType=article, longId=186795, objectId=778b186e9507, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=778b186e9507, replyNumber=0, likeNumber=61, createdTime=2020-01-28, rootId=0, userName=neurosurgeon, userId=bf9f16042984, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=778b186e9507, moduleTitle=JACC: 吗啡和氯吡格雷不要同时用！增加ACS患者缺血事件风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=778b186e9507)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574998, encodeId=98a615e4998d0, content=<a href='/topic/show?id=52ab188e48' target=_blank style='color:#2F92EE;'>#ACS患者#</a>, objectTitle=JAMA Intern Med：PCI后ACS患者主要冠状动脉不良事件的预防——替卡格雷vs氯吡格雷, objectType=article, longId=186599, objectId=149a186599e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=149a186599e2, replyNumber=0, likeNumber=52, createdTime=2020-01-22, rootId=0, userName=neurosurgeon, userId=bf9f16042984, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=149a186599e2, moduleTitle=JAMA Intern Med：PCI后ACS患者主要冠状动脉不良事件的预防——替卡格雷vs氯吡格雷, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=149a186599e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574997, encodeId=72af15e49979e, content=<a href='/topic/show?id=52ab188e48' target=_blank style='color:#2F92EE;'>#ACS患者#</a>, objectTitle=中国ACS患者血脂管理的现状与挑战, objectType=article, longId=178788, objectId=b5e31e878853, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5e31e878853, replyNumber=0, likeNumber=62, createdTime=2019-09-05, rootId=0, userName=neurosurgeon, userId=bf9f16042984, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5e31e878853, moduleTitle=中国ACS患者血脂管理的现状与挑战, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b5e31e878853)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574996, encodeId=b6ea15e49967b, content=<a href='/topic/show?id=52ab188e48' target=_blank style='color:#2F92EE;'>#ACS患者#</a>, objectTitle=Lancet Diabetes Endo：alirocumab可大幅降低新近ACS患者后继心血管事件风险, objectType=article, longId=174849, objectId=fe261e484957, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe261e484957, replyNumber=0, likeNumber=50, createdTime=2019-07-06, rootId=0, userName=neurosurgeon, userId=bf9f16042984, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe261e484957, moduleTitle=Lancet Diabetes Endo：alirocumab可大幅降低新近ACS患者后继心血管事件风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=fe261e484957)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574995, encodeId=38f215e4995fc, content=<a href='/topic/show?id=52ab188e48' target=_blank style='color:#2F92EE;'>#ACS患者#</a>, objectTitle=JAHA：老年ACS患者，不同病程出血和缺血谁破坏力更大？, objectType=article, longId=159919, objectId=28e61599197d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28e61599197d, replyNumber=0, likeNumber=70, createdTime=2019-02-15, rootId=0, userName=neurosurgeon, userId=bf9f16042984, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28e61599197d, moduleTitle=JAHA：老年ACS患者，不同病程出血和缺血谁破坏力更大？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=28e61599197d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574994, encodeId=66ea15e499414, content=<a href='/topic/show?id=52ab188e48' target=_blank style='color:#2F92EE;'>#ACS患者#</a>, objectTitle=心血管难题解惑：70岁以上ACS患者该保守治疗，还是介入治疗？, objectType=article, longId=151345, objectId=72f415134547, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72f415134547, replyNumber=0, likeNumber=74, createdTime=2018-10-20, rootId=0, userName=neurosurgeon, userId=bf9f16042984, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72f415134547, moduleTitle=心血管难题解惑：70岁以上ACS患者该保守治疗，还是介入治疗？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=72f415134547)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574993, encodeId=de9215e4993cc, content=<a href='/topic/show?id=52ab188e48' target=_blank style='color:#2F92EE;'>#ACS患者#</a>, objectTitle=ESC2018丨VERDICT研究：非ST段抬高ACS患者是否应极早期有创评估？, objectType=article, longId=148224, objectId=fbc9148224fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fbc9148224fd, replyNumber=0, likeNumber=65, createdTime=2018-09-06, rootId=0, userName=neurosurgeon, userId=bf9f16042984, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fbc9148224fd, moduleTitle=ESC2018丨VERDICT研究：非ST段抬高ACS患者是否应极早期有创评估？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=fbc9148224fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574992, encodeId=343c15e4992ce, content=<a href='/topic/show?id=52ab188e48' target=_blank style='color:#2F92EE;'>#ACS患者#</a>, objectTitle=ESC2018丨氯吡格雷是ACS患者中合并需口服抗凝药人群的更佳P2Y12i选择用药, objectType=article, longId=147547, objectId=6a2e14e54788, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a2e14e54788, replyNumber=0, likeNumber=71, createdTime=2018-08-29, rootId=0, userName=neurosurgeon, userId=bf9f16042984, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a2e14e54788, moduleTitle=ESC2018丨氯吡格雷是ACS患者中合并需口服抗凝药人群的更佳P2Y12i选择用药, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6a2e14e54788)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574991, encodeId=1afe15e499134, content=<a href='/topic/show?id=52ab188e48' target=_blank style='color:#2F92EE;'>#ACS患者#</a>, objectTitle=JAHA：OSA对接受双重抗血小板治疗的ACS患者血小板功能特征的影响, objectType=article, longId=145190, objectId=09691451901c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=09691451901c, replyNumber=0, likeNumber=62, createdTime=2018-07-27, rootId=0, userName=neurosurgeon, userId=bf9f16042984, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=09691451901c, moduleTitle=JAHA：OSA对接受双重抗血小板治疗的ACS患者血小板功能特征的影响, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=09691451901c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574990, encodeId=759715e49901e, content=<a href='/topic/show?id=52ab188e48' target=_blank style='color:#2F92EE;'>#ACS患者#</a>, objectTitle=Int J Cardiol：ACS患者发生普拉格雷禁忌的比例、长期预后和医疗选择！, objectType=article, longId=140976, objectId=f7b71409e6e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7b71409e6e7, replyNumber=0, likeNumber=50, createdTime=2018-06-19, rootId=0, userName=neurosurgeon, userId=bf9f16042984, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7b71409e6e7, moduleTitle=Int J Cardiol：ACS患者发生普拉格雷禁忌的比例、长期预后和医疗选择！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f7b71409e6e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574989, encodeId=64e715e49898f, content=<a href='/topic/show?id=52ab188e48' target=_blank style='color:#2F92EE;'>#ACS患者#</a>, objectTitle=Int J Cardiol：CHA2DS2-VASc评分与ACS患者冠状动脉疾病的严重程度、残余血小板反应性和长期临床结局的关系！, objectType=article, longId=133069, objectId=d03a13306939, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d03a13306939, replyNumber=0, likeNumber=54, createdTime=2018-03-23, rootId=0, userName=neurosurgeon, userId=bf9f16042984, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d03a13306939, moduleTitle=Int J Cardiol：CHA2DS2-VASc评分与ACS患者冠状动脉疾病的严重程度、残余血小板反应性和长期临床结局的关系！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d03a13306939)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574988, encodeId=4b5215e4988da, content=<a href='/topic/show?id=52ab188e48' target=_blank style='color:#2F92EE;'>#ACS患者#</a>, objectTitle=ACC 2018：SMART-DATE研究：ACS患者PCI后接受6个月DAPT的安全性仍有待商榷, objectType=article, longId=132571, objectId=4a911325e123, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a911325e123, replyNumber=0, likeNumber=75, createdTime=2018-03-17, rootId=0, userName=neurosurgeon, userId=bf9f16042984, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a911325e123, moduleTitle=ACC 2018：SMART-DATE研究：ACS患者PCI后接受6个月DAPT的安全性仍有待商榷, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4a911325e123)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574987, encodeId=977415e49870f, content=<a href='/topic/show?id=52ab188e48' target=_blank style='color:#2F92EE;'>#ACS患者#</a>, objectTitle=Crit Care：ACS患者院前经胸超声心动图检查可早期识别NSTEMI！, objectType=article, longId=129482, objectId=5e4012948279, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e4012948279, replyNumber=0, likeNumber=54, createdTime=2018-02-11, rootId=0, userName=neurosurgeon, userId=bf9f16042984, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e4012948279, moduleTitle=Crit Care：ACS患者院前经胸超声心动图检查可早期识别NSTEMI！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5e4012948279)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ACS患者

2020-05-29

neurosurgeon (审核中...)

前往app查看评论内容

#ACS患者#

双联抗血小板药物多立维®在华上市，进一步提升ACS患者用药依从性

2022-05-23

neurosurgeon (审核中...)

前往app查看评论内容

#ACS患者#

CARDIOVASC DIABETOL：糖化白蛋白（GA）对NSTE-ACS患者经皮冠状动脉介入治疗的预后意义

2022-01-30

neurosurgeon (审核中...)

前往app查看评论内容

#ACS患者#

JACC：采用双重抗血小板治疗的ACS患者或许不需停用氯吡格雷5天后才能进行冠脉搭桥术

2021-03-17

neurosurgeon (审核中...)

前往app查看评论内容

#ACS患者#

EuroIntervention：接受COMBO支架治疗的ACS患者，3个月vs12个月的DAPT结局——REDUCE试验结果

2020-11-14

neurosurgeon (审核中...)

前往app查看评论内容

#ACS患者#

专家访谈:生命至上——PCSK9抑制剂值得被更多ACS患者使用

2020-09-26

neurosurgeon (审核中...)

前往app查看评论内容

#ACS患者#

ESC 2020:ACS患者LDL-C管理：低一些好一些，早一些好一些？！

2020-09-19

neurosurgeon (审核中...)

前往app查看评论内容

#ACS患者#

指南直通车|长期口服抗凝剂NSTE-ACS患者的抗血小板治疗

2020-09-02

neurosurgeon (审核中...)

前往app查看评论内容

#ACS患者#

JACC: 吗啡和氯吡格雷不要同时用！增加ACS患者缺血事件风险

2020-01-28

neurosurgeon (审核中...)

前往app查看评论内容

#ACS患者#

JAMA Intern Med：PCI后ACS患者主要冠状动脉不良事件的预防——替卡格雷vs氯吡格雷

2020-01-22

neurosurgeon (审核中...)

前往app查看评论内容

#ACS患者#

中国ACS患者血脂管理的现状与挑战

2019-09-05

neurosurgeon (审核中...)

前往app查看评论内容

#ACS患者#

Lancet Diabetes Endo：alirocumab可大幅降低新近ACS患者后继心血管事件风险

2019-07-06

neurosurgeon (审核中...)

前往app查看评论内容

#ACS患者#

JAHA：老年ACS患者，不同病程出血和缺血谁破坏力更大？

2019-02-15

neurosurgeon (审核中...)

前往app查看评论内容

#ACS患者#

心血管难题解惑：70岁以上ACS患者该保守治疗，还是介入治疗？

2018-10-20

neurosurgeon (审核中...)

前往app查看评论内容

#ACS患者#

ESC2018丨VERDICT研究：非ST段抬高ACS患者是否应极早期有创评估？

2018-09-06

neurosurgeon (审核中...)

前往app查看评论内容

#ACS患者#

ESC2018丨氯吡格雷是ACS患者中合并需口服抗凝药人群的更佳P2Y12i选择用药

2018-08-29

neurosurgeon (审核中...)

前往app查看评论内容

#ACS患者#

JAHA：OSA对接受双重抗血小板治疗的ACS患者血小板功能特征的影响

2018-07-27

neurosurgeon (审核中...)

前往app查看评论内容

#ACS患者#

Int J Cardiol：ACS患者发生普拉格雷禁忌的比例、长期预后和医疗选择！

2018-06-19

neurosurgeon (审核中...)

前往app查看评论内容

#ACS患者#

Int J Cardiol：CHA2DS2-VASc评分与ACS患者冠状动脉疾病的严重程度、残余血小板反应性和长期临床结局的关系！

2018-03-23

neurosurgeon (审核中...)

前往app查看评论内容

#ACS患者#

ACC 2018：SMART-DATE研究：ACS患者PCI后接受6个月DAPT的安全性仍有待商榷

2018-03-17

neurosurgeon (审核中...)

前往app查看评论内容

#ACS患者#

Crit Care：ACS患者院前经胸超声心动图检查可早期识别NSTEMI！

2018-02-11

科室
- - 订阅+
  - 更多科室
工具
服务